Target
Interleukin-17A
Ligand
BDBM419256
Substrate
n/a
Meas. Tech.
I L-17A Secretion
IC50
<100±n/a nM
Citation
 Musicki, BBouix-Peter, COuvry, GThoreau, E Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T)) US Patent  US10457637 Publication Date 10/29/2019 
Target
Name:
Interleukin-17A
Synonyms:
CTLA8 | Cytotoxic T-lymphocyte-associated antigen 8 | IL-17 | IL17 | IL17A | IL17_HUMAN | il-17a
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17511.44
Organism:
Homo sapiens (Human)
Description:
Q16552
Residue:
155
Sequence:
MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
  
Inhibitor
Name:
BDBM419256
Synonyms:
N-(2,4-dimethylphenyl)-N- isobutyl-3-(S- methylsulfonimidoyl)-4- ((tetrahydro-2H-pyran-4- yl)methoxy)benzene- sulfonamide | US10457637, Compound 142
Type:
Small organic molecule
Emp. Form.:
C25H36N2O5S2
Mol. Mass.:
508.694
SMILES:
CC(C)CN(c1ccc(C)cc1C)S(=O)(=O)c1ccc(OCC2CCOCC2)c(c1)S(C)(=N)=O
Structure:
Search PDB for entries with ligand similarity: